icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022
Back grey_arrow_rt.gif
 
 
 
Treatment with Bulevirtide, with or without PEG-interferon, in HDV infected patients in a real-life setting. Two-year results from the French multicenter early access program
 
 
  AASLD 2022 Nov 4-8

hepD

1114221

1114222

1114223

1114224

1114225

1114226

1114227

1114228

1114229

11142210

missing

11142211